 |
|
|
|
main approaches |
|
| | |
|
 |
- selection of high risk pharmaceutical products (PPs)
- application of novel cleanup, concentration and diagnostic
methods as well as HTSAs for monitoring PPs in environmental, food and
human patient samples
- studies of the mechanisms of action of high risk PPs in vitro, in situ and in vivo
- monitoring fecundity problems in target populations in relation to dietary habits (epidemiological study)
- development of risk management strategies
- establishment of web based knowledge pools, publication and communication of data
|
|
|
|
|
|
